These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33150591)

  • 1. Model-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin.
    Sou T; Hansen J; Liepinsh E; Backlund M; Ercan O; Grinberga S; Cao S; Giachou P; Petersson A; Tomczak M; Urbas M; Zabicka D; Vingsbo Lundberg C; Hughes D; Hobbie SN; Friberg LE
    Clin Pharmacol Ther; 2021 Apr; 109(4):1063-1073. PubMed ID: 33150591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
    Nielsen EI; Cars O; Friberg LE
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4619-30. PubMed ID: 21807983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia.
    Aranzana-Climent V; Hughes D; Cao S; Tomczak M; Urbas M; Zabicka D; Vingsbo Lundberg C; Hansen J; Lindberg J; Hobbie SN; Friberg LE
    Clin Microbiol Infect; 2022 Oct; 28(10):1367-1374. PubMed ID: 35598857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model.
    Kang AD; Smith KP; Berg AH; Truelson KA; Eliopoulos GM; McCoy C; Kirby JE
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339396
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic prediction of first-in-human dose for bispecific CD3/EpCAM T-cell engager antibody M701, using an integrated PK/PD modeling method.
    Song L; Xue J; Zhang J; Li S; Liu D; Zhou T
    Eur J Pharm Sci; 2021 Mar; 158():105584. PubMed ID: 33039565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicin-resistant Escherichia coli.
    Jensen VF; Jakobsen L; Emborg HD; Seyfarth AM; Hammerum AM
    J Antimicrob Chemother; 2006 Jul; 58(1):101-7. PubMed ID: 16709594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of aparmycin-resistant Escherichia coli from humans in Korea.
    Lim SK; Nam HM; Kim A; Jang GC; Lee HS; Jung SC
    Microb Drug Resist; 2011 Dec; 17(4):563-6. PubMed ID: 21905874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apramycin: minimal inhibitory concentrations for avian Escherichia coli and serum levels after intramuscular injection in turkeys.
    Freidlin PJ; Bock R; Bernath A; Hoexter S; Ziv G; Fromer A; Perlstein Z; Tomer S; Samberg Y
    J Vet Pharmacol Ther; 1985 Mar; 8(1):105-9. PubMed ID: 3886930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin.
    Bordeleau E; Stogios PJ; Evdokimova E; Koteva K; Savchenko A; Wright GD
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
    Juhas M; Widlake E; Teo J; Huseby DL; Tyrrell JM; Polikanov YS; Ercan O; Petersson A; Cao S; Aboklaish AF; Rominski A; Crich D; Böttger EC; Walsh TR; Hughes D; Hobbie SN
    J Antimicrob Chemother; 2019 Apr; 74(4):944-952. PubMed ID: 30629184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose.
    Zhao C; Chirkova A; Rosenborg S; Palma Villar R; Lindberg J; Hobbie SN; Friberg LE
    J Antimicrob Chemother; 2022 Sep; 77(10):2718-2728. PubMed ID: 35849148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibiotics.
    Kitamura Y; Yoshida K; Kusama M; Sugiyama Y
    Drug Metab Pharmacokinet; 2014; 29(6):455-62. PubMed ID: 25008846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacometric approach to define target site-specific breakpoints for bacterial killing and resistance suppression integrating microdialysis, time-kill curves and heteroresistance data: a case study with moxifloxacin.
    Iqbal K; Broeker A; Nowak H; Rahmel T; Nussbaumer-Pröll A; Österreicher Z; Zeitlinger M; Wicha SG
    Clin Microbiol Infect; 2020 Sep; 26(9):1255.e1-1255.e8. PubMed ID: 32088331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods.
    Song L; Yao X; Liu Y; Zhong W; Jiang J; Liu H; Zhou H; Shi C; Zong K; Wang C; Ma C; Liu D; Hu P
    Eur J Pharm Sci; 2020 Apr; 147():105281. PubMed ID: 32126254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic-pharmacodynamic (PKPD) model based on in vitro time-kill data predicts the in vivo PK/PD index of colistin.
    Khan DD; Friberg LE; Nielsen EI
    J Antimicrob Chemother; 2016 Jul; 71(7):1881-4. PubMed ID: 26983860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apramycin treatment affects selection and spread of a multidrug-resistant Escherichia coli strain able to colonize the human gut in the intestinal microbiota of pigs.
    Herrero-Fresno A; Zachariasen C; Hansen MH; Nielsen A; Hendriksen RS; Nielsen SS; Olsen JE
    Vet Res; 2016 Jan; 47():12. PubMed ID: 26739225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tentative epidemiologic cut-off value and resistant characteristic detection of apramycin against Escherichia coli from chickens.
    Tian E; Muhammad I; Hu W; Wu Z; Li R; Lu X; Chen C; Li J
    FEMS Microbiol Lett; 2019 Aug; 366(16):. PubMed ID: 31518404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic disposition, systemic bioavailability and tissue distribution of apramycin in broiler chickens.
    Afifi NA; Ramadan A
    Res Vet Sci; 1997; 62(3):249-52. PubMed ID: 9300543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apramycin and gentamicin resistances in indicator and clinical Escherichia coli isolates from farm animals in Korea.
    Choi MJ; Lim SK; Nam HM; Kim AR; Jung SC; Kim MN
    Foodborne Pathog Dis; 2011 Jan; 8(1):119-23. PubMed ID: 21214385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.